Literature DB >> 18520589

Squamous cell carcinoma of the temporal bone: results and management.

Henricus Kunst1, Jean-Pierre Lavieille, Henri Marres.   

Abstract

OBJECTIVE: Evaluation of the management and survival of patients treated for temporal bone squamous cell carcinoma. STUDY
DESIGN: A retrospective analysis.
SETTING: Tertiary care, academic referral center. PATIENTS: Twenty-eight patients underwent primary treatment for squamous cell carcinoma of the temporal bone.
INTERVENTIONS: The patients were staged using the modified Pittsburgh staging system. Patients underwent a local resection, lateral temporal bone resection, or a subtotal lateral temporal bone resection usually followed by radiotherapy. MAIN OUTCOME MEASURE: The survival rate of patients grouped by tumor size was calculated.
RESULTS: Staging revealed 12 pT1, 2 pT2, 4 pT3, and 10 pT4 tumors. The mean follow-up was 34 months (2-132 mo). The Kaplan-Meier survival curves showed survival rates at 5 years of 83 and 25% for the stages pT1 and pT4, respectively. The pooled survival curves showed survival rates at 5 years of 85 and 46% for the stages pT1p/T2 and pT3/pT4, respectively.
CONCLUSION: Long-term prognosis of the carcinoma of the external auditory canal mainly depends on the stage and primary treatment. Surgery may consist of a lateral temporal bone or subtotal temporal bone resection; in T3 and T4 tumors, resection may be combined with a superficial parotidectomy. If disease is diagnosed in the neck or parotid, then a neck dissection and total parotidectomy may also be performed. Additional radiotherapy should be provided in incompletely resected T1 and all T2 and T3 tumors and part of the T4 tumors. T4 tumors may be treated according to their subclassification based on the anatomic extension.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18520589     DOI: 10.1097/MAO.0b013e31816c7c71

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  21 in total

1.  Predictors of survival and recurrence after temporal bone resection for cancer.

Authors:  Luc G T Morris; Saral Mehra; Jatin P Shah; Mark H Bilsky; Samuel H Selesnick; Dennis H Kraus
Journal:  Head Neck       Date:  2011-09-23       Impact factor: 3.147

2.  Outcomes following temporal bone resection.

Authors:  Nichole R Dean; Hilliary N White; Dale S Carter; Renee A Desmond; William R Carroll; Benjamin M McGrew; Eben L Rosenthal
Journal:  Laryngoscope       Date:  2010-08       Impact factor: 3.325

3.  Treatment and outcome of middle ear cancer.

Authors:  Xianhao Jia; Qin Liang; Fanglu Chi
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10       Impact factor: 2.503

4.  Lateral temporal bone resection in advanced cutaneous squamous cell carcinoma: report of 35 patients.

Authors:  Garth F Essig; Leon Kitipornchai; Felicity Adams; Dannie Zarate; Mitesh Gandhi; Sandro Porceddu; Benedict Panizza
Journal:  J Neurol Surg B Skull Base       Date:  2012-12-12

Review 5.  Temporal bone resection for lateral skull-base malignancies.

Authors:  Gautam U Mehta; Thomas J Muelleman; Derald E Brackmann; Paul W Gidley
Journal:  J Neurooncol       Date:  2020-02-27       Impact factor: 4.130

6.  Concomitant chemoradiotherapy as a standard treatment for squamous cell carcinoma of the temporal bone.

Authors:  Kiyoto Shiga; Takenori Ogawa; Atsuko Maki; Masanori Amano; Toshimitsu Kobayashi
Journal:  Skull Base       Date:  2011-05

7.  Temporal bone carcinoma: Treatment patterns and survival.

Authors:  Kristen L Seligman; Daniel Q Sun; Patrick P Ten Eyck; Nathan M Schularick; Marlan R Hansen
Journal:  Laryngoscope       Date:  2019-03-15       Impact factor: 3.325

8.  The misdiagnosis of external auditory canal carcinoma.

Authors:  Ting Zhang; ChunFu Dai; ZhengMin Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-25       Impact factor: 2.503

Review 9.  Temporal bone verrucous carcinoma: outcomes and treatment controversy.

Authors:  Mia E Miller; Neil Martin; Guy F Juillard; Sunita Bhuta; Akira Ishiyama
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-05-26       Impact factor: 2.503

10.  Prognostic models to predict overall and cause-specific survival for patients with middle ear cancer: a population-based analysis.

Authors:  Weidong Shen; Naoko Sakamoto; Limin Yang
Journal:  BMC Cancer       Date:  2014-08-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.